Press release
Cancer Nanomedicine Market Size to Reach USD 445.67 Billion by Forecast 2030, Trends, Demands, Regional Analysis and Growth Factors
Cancer Nanomedicine Market
According to the International Agency for Research on Cancer, there will be 10.3 million cancer deaths and 19.3 million new cancer cases worldwide in 2020. Furthermore, 16.4 million people are expected to die from cancer-related causes by 2040, with 29.5 million new patients diagnosed each year. One of the primary reasons for the increasing prominence of nanomedicine is the rise in the prevalence of chronic diseases such as cancer and cardiovascular disease. Furthermore, the market for cancer nanomedicine is expanding due to increased number of patients with high blood pressure, obesity, and other cardiovascular diseases, among other factors.
Data Bridge Market Research analyses that the cancer nanomedicine market which was USD 180 billion in 2022, is expected to reach USD 445.67 billion by 2030, at a CAGR of 12% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Cancer Nanomedicine market study analyses the market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. This report makes to focus on the more important aspects of the market like what the market recent trends are. Analysis and estimations attained through the massive information gathered in this market research report are extremely necessary when it comes to dominating the market or creating a mark in the market as a new emergent.
Opportunities
Increasing Demand for Nanomedicines
The growing demand for nanomedicines can be attributed to the rapidly expanding applications of nanomaterials such as nanocapsules and nanotubes in drug delivery systems. The rise in cancer and cardiovascular disease incidences has boosted demand for nanomedicines, resulting in increased public and private investment in nanomedicine research and advancements in biodegradable nanoparticles. The cost-effectiveness and fewer side effects of these therapies are also major drivers of the cancer nanomedicine industry's growth.
Segmentation:
The cancer nanomedicine market is segmented on the basis of type, agent type, mechanism, cancer type, imaging technique, and phase. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Inorganic Nanoparticles
Synthesis of gold nanoparticle
Organic Nanoparticles
Polymeric nanoparticle
lipid organic nanoparticles
Agent Type
Diagnostic Agents
Cancer biomarkers
Diagnostic device
Biosensors
Microarrays
Nanoprobes
Quantum dots
Therapeutic Agents
Photodynamic therapy
Photo thermal therapy
Drug Delivery Agents
Mechanism
Targeting Tumor Cells
Passive targeting
Active targeting
Nanocarrier - Drug Complex
Liposomes
Dendrimers
Micelles
Inorganic nanocarriers
Drug Release Systems
Cancer Type
Breast Cancer
Pancreatic Cancer
Brain Cancer
Lung Cancer
Others
Imaging Technique
Positron Emission Tomography
Single Photon Emitted Tomography
Magnetic Resonance Imaging (MRI)
Phase
Research
Preclinical
Phase-I
Phase-I/II
Phase-II
Phase-III
Key Market Players:
Alnylam Pharmaceuticals, Inc. (U.S.)
Amgen Inc. (U.S.)
Arrowhead Pharmaceuticals, Inc. (U.S.)
AstraZeneca (U.K.)
Cadila Pharmaceuticals (India)
CELGENE CORPORATION (U.S.)
Celsion Corporation (U.S.)
Genzyme (U.S.)
Merck & Co., Inc. (U.S.)
Nippon Kayaku Co.Ltd. (Japan)
Nanobiotix (France)
Pfizer Inc. (U.S.)
Hoffmann-La Roche Ltd (Switzerland)
Takeda Pharmaceutical Company Limited (Japan)
General Electric (U.S.)
Johnson & Johnson Services, Inc. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Gilead Sciences, Inc. (U.S.)
Novartis AG (Switzerland)
Attractions of The Cancer Nanomedicine Market Report: -
Latest market dynamics, development trends and growth opportunities are presented along with industry barriers, developmental threats and risk factors
The forecast Cancer Nanomedicine Market data will help in the feasibility analysis, market size estimation and development
The report serves as a complete guide which micro monitors all vital Cancer Nanomedicine Market
A concise market view will provide ease of understanding.
Nut Oil Market Competitive market view will help the players in making a right move
Key Questions Answered
What impact does COVID-19 have made on Global Cancer Nanomedicine Market Growth & Sizing?
Who are the Leading key players and what are their Key Business plans in the Global Cancer Nanomedicine Market?
What are the key concerns of the five forces analysis of the Global Cancer Nanomedicine Market?
What are different prospects and threats faced by the dealers in the Global Cancer Nanomedicine Market?
What are the strengths and weaknesses of the key vendors?
Browse More Info @ https://www.databridgemarketresearch.com/reports/global-cancer-nanomedicine-market
More reports;
https://sagark18dbmr.blogspot.com/2023/05/esthesioneuroblastoma-treatment-market.html
https://sagark18dbmr.blogspot.com/2023/05/nitrile-butadiene-rubber-nbr-gloves.html
https://sagark18dbmr.blogspot.com/2023/05/thoracic-aortic-stent-grafts-market.html
https://sagark18dbmr.blogspot.com/2023/05/pre-lit-disposable-vaginal-speculum.html
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email - corporatesales@databridgemarketresearch.com
About Us:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Nanomedicine Market Size to Reach USD 445.67 Billion by Forecast 2030, Trends, Demands, Regional Analysis and Growth Factors here
News-ID: 3070716 • Views: …
More Releases from DBMR
Feed Pigments Market - Industry Trends and Forecast
Global Feed Pigments Market, By Type (Carotenoids, Curcumin, Caramel, Spirulina and Others), Carotenoids Source (Natural and Synthetic), Livestock (Swine, Poultry, Ruminants, Aquatic Animals and Others) - Industry Trends and Forecast to 2029.
Feed Pigments Market Analysis and Size
Feed pigments are used to enhance the colour of products such as eggs, meat, and milk. The key drivers for this market are rising meat production demand, rising disposable incomes, a shift toward pellet…
Automatic Brewing Equipment Market - Industry Trends and Forecast
Global Automatic Brewing Equipment Market, By Brewery Type (Macrobrewery, Craft Brewery), Equipment Type (Macrobrewery Equipment, Craft Brewery Equipment), Material Type (Brass, CopperAluminumStainless steel, Mild steel) - Industry Trends and Forecast to 2029.
Automatic Brewing Equipment Market Analysis and Size
Beers provide antioxidants and are a low-calorie alternative to other drinks. Along with being appropriately rich in vitamin B, vitamin B3, and vitamin B6, it also gives our bodies with vital fibre content.…
Digestive Health Food and Drinks Market - Industry Trends and Forecast
Data Bridge Market Research analyses that the global digestive health food and drinks market to account USD 63.43 billion by 2029 growing at a CAGR of 7.85% in the forecast period of 2022-2029.
Digestive health drinks are products that help to counteract the effects of an overburdened digestive tract. Drinks, when consumed properly, can aid in the prevention of a variety of small and large intestine health problems. There are…
Activin A Market Size, Share, Growth, Trends and Forecast
Activin A market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 12.50% in the above mentioned forecast period.
Activin A is a member of the TGF-beta super family and shows structural similarities with TGF-beta 1. Activins are the disulphide linked dimeric proteins that causes stimulation of pituitary follicle stimulating hormone…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
